BeiGene Newsroom

Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $284

Moomoo NewsSep 30 08:31 ET

BeiGene Initiated at Market Outperform by JMP Securities

Dow JonesSep 18 05:52 ET

JMP Securities Initiates Coverage On BeiGene With Market Outperform Rating, Announces Price Target of $288

BenzingaSep 18 05:42 ET

BeiGene Analyst Ratings

BenzingaSep 18 05:42 ET

JMP Securities Initiates BeiGene(BGNE.US) With Buy Rating, Announces Target Price $288

Moomoo NewsSep 18 01:32 ET

BofA Securities Maintains BeiGene(BGNE.US) With Hold Rating, Maintains Target Price $198

Moomoo NewsSep 10 08:31 ET

Hold Rating on BeiGene Amid Mixed Sales Performance and Competitive Pressures

TipRanksSep 10 07:44 ET

Morgan Stanley Maintains BeiGene(BGNE.US) With Buy Rating, Cuts Target Price to $307

Moomoo NewsAug 26 09:31 ET

Morgan Stanley Maintains BeiGene(BGNE.US) With Buy Rating, Cuts Target Price to $307

Moomoo NewsAug 24 10:31 ET

BeiGene Analyst Ratings

BenzingaAug 20 10:14 ET

J.P. Morgan Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $200

Moomoo NewsAug 20 08:33 ET

TD Cowen Initiates BeiGene(BGNE.US) With Buy Rating, Announces Target Price $254

Moomoo NewsAug 19 07:32 ET

TD Cowen Sticks to Its Buy Rating for BeiGene (BGNE)

TipRanksAug 19 07:01 ET

Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $284

Moomoo NewsAug 16 09:32 ET

Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $284

Moomoo NewsAug 16 08:32 ET

Jefferies Sticks to Their Buy Rating for BeiGene (BGNE)

TipRanksAug 16 08:07 ET

BofA Securities Maintains BeiGene(BGNE.US) With Hold Rating, Raises Target Price to $198

Moomoo NewsAug 13 10:32 ET

Hold Rating on BeiGene Amid Mixed Drug Performance and Strong Pipeline Potential

TipRanksAug 13 10:21 ET

BeiGene's Strong Financial and Clinical Prospects Solidify Buy Rating

TipRanksAug 9 12:27 ET

BeiGene Analyst Ratings

BenzingaAug 8 15:14 ET